# American Shared Hospital Services

> Clarifo company profile — qualitative business description generated from
> the company's filings. Financial statements, charts and ratios are
> available on Clarifo (https://www.clarifo.com/en/companies/American Shared Hospital Services).

## Overview

American Shared Hospital Services finances and operates advanced radiation therapy technology through two models: leasing medical equipment to hospitals and running its own radiation therapy centers that bill patients and payors directly. Its installed base includes Gamma Knife stereotactic radiosurgery systems, LINAC radiation therapy systems, and a proton beam radiation therapy (PBRT) system under contract arrangements. In the leasing segment, revenue is tied to procedure volumes via fee-per-use pricing or revenue-sharing on hospital reimbursements, typically under long-term contracts. In direct patient services, the company operates single-unit centers in Rhode Island and international facilities in Peru, Ecuador, and Mexico, where it provides radiation treatments as the principal under patient contracts.

## Products & services

• Gamma Knife system leasing (fee-per-use and revenue share)
• PBRT system leasing at Orlando Health (revenue share)
• LINAC system leasing arrangements
• Direct patient radiation therapy services (Rhode Island centers)
• Direct patient Gamma Knife services (Peru and Ecuador centers)
• Direct patient LINAC services (Puebla, Mexico)
• Equipment service/maintenance coordination (Elekta, Mevion, etc.)

- **Medical equipment leasing (Gamma Knife)** (45%) — Leasing of Gamma Knife radiosurgery systems to hospitals under fee-per-use or revenue-sharing contracts.
- **Medical equipment leasing (PBRT)** (25%) — Proton beam radiation therapy leasing under a revenue-sharing model tied to reimbursement and utilization.
- **Medical equipment leasing (LINAC)** (10%) — Leasing of LINAC radiation therapy systems, with economics driven by procedure volume and contract terms.
- **Direct patient services (U.S. centers)** (15%) — Radiation therapy treatments delivered at company-operated single-unit centers in Rhode Island billed to patients/payors.
- **Direct patient services (International centers)** (5%) — Company-operated Gamma Knife and LINAC facilities in Latin America providing treatments under patient contracts.

- Gamma Knife system leasing (fee-per-use and revenue share)
- PBRT system leasing at Orlando Health (revenue share)
- LINAC system leasing arrangements
- Direct patient radiation therapy services (Rhode Island centers)
- Direct patient Gamma Knife services (Peru and Ecuador centers)
- Direct patient LINAC services (Puebla, Mexico)
- Equipment service/maintenance coordination (Elekta, Mevion, etc.)

## Customers

The leasing segment’s customers are hospitals and health systems that want access to high-cost radiation therapy equipment without fully owning and operating the asset. These hospital customers pay either per procedure (fee-per-use) or share a contracted percentage of reimbursement received, which makes utilization and payer mix central to economics. The direct patient services segment serves cancer patients referred for stereotactic radiosurgery or radiation therapy at company-operated centers, with reimbursement coming from government and commercial payors. The company’s customer mix therefore spans institutional counterparties (hospitals) and healthcare consumers (patients), with demand influenced by clinical volumes, referral patterns, and reimbursement rates.

- **U.S. hospitals/health systems (leasing)** (primary) — Lease Gamma Knife, LINAC, and PBRT capacity via fee-per-use or revenue-sharing to provide radiation therapy without owning the equipment outright.
- **U.S. patients at company-operated centers (direct patient services)** (secondary) — Receive radiation therapy at the Rhode Island facilities where the company acts as principal and recognizes treatment revenue at the time of service.
- **International patients at company-operated centers** (emerging) — Receive Gamma Knife or LINAC treatments at facilities in Peru, Ecuador, and Mexico, expanding the direct patient services model outside the U.S.
- **Equipment OEM/service vendors (ecosystem partners)** (secondary) — Provide maintenance and service coverage (e.g., Elekta, Mevion) that supports uptime and contractual performance for leased and owned systems.

- U.S. hospitals leasing Gamma Knife systems to avoid upfront capex
- Hospitals using revenue-share contracts tied to reimbursement collections
- Orlando Health PBRT site under a revenue-sharing arrangement
- Patients treated at Rhode Island radiation therapy centers (direct billing)
- Patients treated at company-owned Gamma Knife centers in Peru and Ecuador
- Patients treated at the Puebla, Mexico LINAC center (started treating July 2024)
- Payors (CMS/commercial) indirectly drive economics via reimbursement levels

## Geography

Operations are primarily U.S.-based, with leased Gamma Knife, LINAC, and PBRT systems under contract with domestic hospitals and direct patient services centers in Rhode Island. Internationally, the company owns and operates Gamma Knife facilities in Lima, Peru and Guayaquil, Ecuador, and a LINAC center in Puebla, Mexico that began treating patients in July 2024. The geographic footprint matters because reimbursement dynamics are U.S.-centric for leasing economics (including CMS rates), while international centers introduce local demand, regulatory, and currency/collection considerations. The company’s installed base can shift over time as contracts start/end, affecting where procedure volume and revenue are generated.

- United States is the core market for equipment leasing contracts
- Rhode Island: three stand-alone radiation therapy centers (direct services)
- Peru: Lima Gamma Knife single-unit facility (direct services)
- Ecuador: Guayaquil Gamma Knife single-unit facility (direct services)
- Mexico: Puebla single-unit LINAC facility (direct services; started July 2024)
- U.S. reimbursement (CMS) is a key driver of leasing economics
- International sites add regulatory and collection/currency complexity

## Strategy

The company’s strategy centers on expanding and optimizing a contracted installed base of radiation therapy systems while balancing two operating models: hospital leasing and direct patient services. Acquiring a majority stake in the Rhode Island centers and launching the Puebla, Mexico facility indicate a push to grow direct patient services where the company controls operations and patient contracting. In leasing, the focus is on structuring fee-per-use and revenue-sharing contracts that align returns with procedure volumes and reimbursement, typically over long contract terms. Operationally, maintaining equipment uptime through third-party service agreements is critical to protecting procedure capacity and revenue realization.

- **Scale direct patient services footprint** (medium-term) — Owned centers allow the company to contract directly with patients and capture economics beyond equipment leasing.
- **Stabilize and optimize leasing utilization** (short-term) — Leasing revenue is driven by procedure volume and reimbursement under fee-per-use and revenue-sharing arrangements.
- **Ensure equipment uptime and cost control through service arrangements** (short-term) — Service commitments and maintenance execution affect capacity, patient throughput, and profitability at both leased and owned sites.

- Grow direct patient services via owned single-unit centers (Rhode Island, LatAm)
- Maintain/renew long-term leasing contracts for Gamma Knife and PBRT systems
- Use fee-per-use and revenue-share structures to match pricing to utilization
- Improve procedure volumes through site optimization and referral development
- Secure project financing for new systems and facility investments
- Manage vendor service contracts to protect uptime and patient throughput

## Risks

Revenue is highly sensitive to procedure volumes at each site, because leasing contracts generally lack guaranteed minimum payments and direct patient services depend on patient throughput and referrals. Reimbursement risk is central: changes in CMS rates, coding, or payer policies can reduce the reimbursement pool that underpins fee-per-use pricing and revenue-sharing receipts. The business also carries execution risk around equipment uptime and service costs, given reliance on third-party maintenance providers and significant service commitments. International operations in Peru, Ecuador, and Mexico add regulatory, collection, and currency risks relative to the U.S. base, while new site development and equipment financing availability can constrain growth or pressure returns.

- **Procedure volume declines reduce revenue and profitability** [high] — Leasing revenue is recognized per procedure or as a share of reimbursement, and direct patient services depend on patient throughput; lower volumes drove segment losses in the quarter discussed.
- **Reimbursement and coding changes (CMS/commercial) pressure economics** [high] — Contract receipts are tied to reimbursement levels (directly for revenue share and indirectly for demand), so payer policy changes can reduce revenue per treatment.
- **Service and uptime risk from reliance on third-party maintenance** [medium] — The company has significant service commitments and depends on vendors to keep systems operational; downtime reduces procedures and can raise costs.
- **International operating risk in Latin America** [medium] — Owned facilities in Peru, Ecuador, and Mexico face local regulatory requirements, collections variability, and potential currency impacts versus U.S. operations.

- Procedure volume volatility directly impacts revenue in both segments
- No guaranteed minimums in many leasing contracts increases downside risk
- CMS and commercial reimbursement changes can compress revenue share pools
- Estimation risk in revenue-sharing arrangements and cost-sharing components
- Equipment downtime/service execution risk affects patient throughput
- Large service commitments can pressure margins if utilization is weak
- International regulatory, collection, and currency risks (Peru/Ecuador/Mexico)
- Financing availability risk for new equipment and facility projects

## Accounting

Reported revenue depends heavily on contract type and estimation. Leasing revenues are recognized under ASC 842 either at the time procedures are performed (fee-per-use) or based on estimated reimbursement collections under revenue-sharing arrangements, which requires management judgment and periodic true-ups. Some revenue-sharing contracts include cost-sharing components, requiring estimates of operating costs that affect both revenue and other direct operating costs. Management identifies critical estimates around revenue recognition for revenue-sharing arrangements, business combination accounting (e.g., the Rhode Island acquisition), salvage value assumptions, and the carrying value and useful lives of property and equipment, all of which can change depreciation and impairment risk. Because revenue is procedure-driven, quarterly results can fluctuate with site volumes and reimbursement timing, affecting comparability across periods.

- **Revenue recognition for fee-per-use vs revenue-sharing (ASC 842)** — Affects timing/amount of leasing revenue and related receivables
- **Direct patient services revenue recognition (ASC 606)** — Affects gross vs net presentation and timing of patient-service revenue
- **Cost estimates in revenue-sharing arrangements** — Affects other direct operating costs and segment profitability
- **Property & equipment estimates (useful lives, salvage values, carrying value)** — Affects depreciation expense and potential impairment charges
- **Business combination accounting (Rhode Island acquisition)** — Affects balance sheet and future earnings through amortization/impairment

- ASC 842 leasing revenue recognized per procedure or via revenue-share estimates
- Revenue-sharing requires estimating reimbursement collections and true-ups
- Cost-sharing components require estimating operating costs in COGS/opex
- ASC 606 direct patient services: principal; point-in-time treatment revenue
- Business combination accounting for RI Companies affects goodwill/intangibles
- Salvage value and useful life estimates drive depreciation expense
- Property & equipment carrying values may require impairment judgments
- Procedure-volume variability can drive quarter-to-quarter revenue swings

---

*Last updated: 2026-08-11T04:46:17.811758+00:00*